PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DNA vs. POWW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

DNA vs. POWW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ginkgo Bioworks Holdings, Inc. (DNA) and AMMO, Inc. (POWW). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-74.88%
-47.07%
DNA
POWW

Returns By Period

In the year-to-date period, DNA achieves a -90.25% return, which is significantly lower than POWW's -40.00% return.


DNA

YTD

-90.25%

1M

-29.74%

6M

-74.90%

1Y

-88.06%

5Y (annualized)

N/A

10Y (annualized)

N/A

POWW

YTD

-40.00%

1M

6.78%

6M

-47.06%

1Y

-40.57%

5Y (annualized)

-3.44%

10Y (annualized)

N/A

Fundamentals


DNAPOWW
Market Cap$370.74M$156.76M
EPS-$12.89-$0.21
Total Revenue (TTM)$217.95M$107.38M
Gross Profit (TTM)$138.89M$23.27M
EBITDA (TTM)-$626.41M-$3.02M

Key characteristics


DNAPOWW
Sharpe Ratio-0.89-0.66
Sortino Ratio-2.22-0.72
Omega Ratio0.760.91
Calmar Ratio-0.89-0.46
Martin Ratio-1.37-1.24
Ulcer Index64.65%32.98%
Daily Std Dev99.09%61.52%
Max Drawdown-99.10%-88.97%
Current Drawdown-98.90%-87.13%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.4

The correlation between DNA and POWW is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

DNA vs. POWW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and AMMO, Inc. (POWW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DNA, currently valued at -0.89, compared to the broader market-4.00-2.000.002.004.00-0.89-0.66
The chart of Sortino ratio for DNA, currently valued at -2.22, compared to the broader market-4.00-2.000.002.004.00-2.22-0.72
The chart of Omega ratio for DNA, currently valued at 0.76, compared to the broader market0.501.001.502.000.760.91
The chart of Calmar ratio for DNA, currently valued at -0.89, compared to the broader market0.002.004.006.00-0.89-0.46
The chart of Martin ratio for DNA, currently valued at -1.37, compared to the broader market0.0010.0020.0030.00-1.37-1.24
DNA
POWW

The current DNA Sharpe Ratio is -0.89, which is lower than the POWW Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of DNA and POWW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.89
-0.66
DNA
POWW

Dividends

DNA vs. POWW - Dividend Comparison

Neither DNA nor POWW has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DNA vs. POWW - Drawdown Comparison

The maximum DNA drawdown since its inception was -99.10%, which is greater than POWW's maximum drawdown of -88.97%. Use the drawdown chart below to compare losses from any high point for DNA and POWW. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%JuneJulyAugustSeptemberOctoberNovember
-98.90%
-87.13%
DNA
POWW

Volatility

DNA vs. POWW - Volatility Comparison

Ginkgo Bioworks Holdings, Inc. (DNA) has a higher volatility of 27.24% compared to AMMO, Inc. (POWW) at 24.11%. This indicates that DNA's price experiences larger fluctuations and is considered to be riskier than POWW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
27.24%
24.11%
DNA
POWW

Financials

DNA vs. POWW - Financials Comparison

This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and AMMO, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items